Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Range of CR at 450 day mark

<< Previous

Bullboard Posts

Next >>

Comment by N0taP00pon Apr 05, 2023 9:29pm

138 Views

Post# 35382290

RE:RE:RE:RE:Range of CR at 450 day mark

Just took the absolute value delta, that's all. The way you stated it is what I expect TLT to use in their pitch to both the FDA and the public. "We're 50% better than Keytruda!!" Thanks for the feedback. You must work in Marketing.

<< Previous

Bullboard Posts

Next >>

The top 10 Canadian medical stocks